Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001144204-17-028874

Options or other derivatives

  • President and CEO acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FROM STEPHEN · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-05-18 Grant or award : show line 1 in the form Stock Option (right to buy) +25,000 $1.80 2027-05-18 25,000 25,000 D
Loading xslF345X03/v467586_4.xml…